Considering that COX-2 is a similar inflammatory mediator, catalyzing the conversion of arachidonic acid into prostaglandins, it should be of interest to investigate whether a combination of 5-LO and COX-2 inhibitors would exert a more pronounced effect on global cerebral ischemia-reperfusion injury than either inhibitor alone. This evidence concerns the gene ALOX5 and brain ischemia.